臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至:
或輸入年份:

從最近的開始

由舊到新排序

顯示項目 2263166-2263190 / 2346973 (共93879頁)
<< < 90522 90523 90524 90525 90526 90527 90528 90529 90530 90531 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-03-08T03:44:00Z	C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin �\v	Kuo T.-C.; Wu M.-H.; SHIH-HUNG YANG; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C.
臺大學術典藏	2022-03-08T03:44:01Z	A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study	Su Y.-Y.; Chiu Y.-F.; Li C.-P.; SHIH-HUNG YANG; Lin J.; Lin S.-J.; Chang P.-Y.; Chiang N.-J.; Shan Y.-S.; Ch��ang H.-J.; Chen L.-T.
臺大學術典藏	2022-03-08T03:44:01Z	Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study	Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C.
臺大學術典藏	2022-03-08T03:44:01Z	Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma	SHIH-HUNG YANG; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-08T03:44:01Z	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2022-03-08T03:44:02Z	S-1�Vassociated hypertriglyceridemia in a patient with pancreatic adenocarcinoma	Chen H.-W.; Kuo H.-Y.; Chen B.-B.; Tien Y.-W.; Kuo S.-H.; SHIH-HUNG YANG
臺大學術典藏	2022-03-08T03:44:02Z	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study	Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2022-03-08T03:44:02Z	Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients	SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-08T03:44:03Z	Postoperative imaging and tumor marker surveillance in resected pancreatic cancer	Wu H.; Guo J.-C.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:03Z	A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma	SHIH-HUNG YANG; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-08T03:44:03Z	Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer	Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; SHIH-HUNG YANG; Wu C.-H.; Kuo T.-C.; Shih I.-L.; Yen R.-F.; Shih T.T.-F.
臺大學術典藏	2022-03-08T03:44:04Z	Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy	SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-08T03:44:04Z	Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan	Chang M.-C.; Wu C.-H.; SHIH-HUNG YANG; Liang P.-C.; Chen B.-B.; Jan I.-S.; Chang Y.-T.; Jeng Y.-M.
臺大學術典藏	2022-03-08T03:44:04Z	Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer	SHIH-HUNG YANG; Guo J.-C.; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:05Z	PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis	Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; Wu C.-H.; Chen X.-J.; Kuo T.-C.; SHIH-HUNG YANG; Shih I.-L.; Lai H.-S.; Shih T.T.-F.
臺大學術典藏	2022-03-08T03:44:05Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:05Z	Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma	Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; Yang C.-Y.; Tien Y.-W.; SHIH-HUNG YANG; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H.
臺大學術典藏	2022-03-08T03:44:06Z	Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: A retrospective study	Guo J.-C.; SHIH-HUNG YANG
臺大學術典藏	2022-03-08T03:44:06Z	Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-�eb is associated with a poor prognosis of pancreatic cancer	SHIH-HUNG YANG; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏	2022-03-08T03:44:06Z	Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy	Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2022-03-08T03:44:07Z	Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma	SHIH-HUNG YANG; Lin L.-W.; Fang Y.-J.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:07Z	A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor	SHIH-HUNG YANG; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; Hong R.-L.
臺大學術典藏	2022-03-08T03:44:07Z	Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials	SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏	2022-03-08T03:44:08Z	Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma	SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏	2022-03-08T03:44:08Z	Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [2]	SHIH-HUNG YANG; Kuo S.-H.

顯示項目 2263166-2263190 / 2346973 (共93879頁)
<< < 90522 90523 90524 90525 90526 90527 90528 90529 90530 90531 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2854037
	造訪人次 : 45416917 線上人數 : 2348 教育部委託研究計畫計畫執行:國立臺灣大學圖書館